Woodley Farra Manion Portfolio Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$70.1M Buy
369,477
+508
+0.1% +$95.5K 3.37% 8
2026
Q1
$72.8M Sell
368,969
-4,811
-1% -$928K 3.54% 6
2025
Q4
$68.7M Sell
373,780
-2,627
-0.7% -$461K 3.27% 11
2025
Q3
$57.8M Sell
376,407
-3,811
-1% -$577K 2.72% 18
2025
Q2
$53.1M Buy
+380,218
New +$53.3M 2.5% 18
2024
Q4
Sell
-1,520
Closed -$237K 100
2024
Q3
$237K Buy
1,520
+17
+1% +$2.74K 0.01% 92
2024
Q2
$234K Hold
1,503
0.01% 89
2024
Q1
$204K Hold
1,503
0.01% 103
2023
Q4
$202K Hold
1,503
0.01% 95
2023
Q3
$204K Buy
+1,503
New +$205K 0.01% 94

Other funds holding AZN

Woodley Farra Manion Portfolio Management's AZN Position: Q2 2026 in Review

Woodley Farra Manion Portfolio Management increased its AstraZeneca (AZN) stake by 0.14% in Q2 2026, buying an estimated $95.5K and bringing the position to 369,477 shares worth $70.1M. The position accounts for 3.37% of the portfolio, ranked #8.

Woodley Farra Manion Portfolio Management first reported a position in AZN in Q3 2023 and has held it in 10 quarters since. The position peaked at $72.8M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Woodley Farra Manion Portfolio Management held 369,477 shares of AstraZeneca worth $70.1M as of Q2 2026.
  • Woodley Farra Manion Portfolio Management bought 508 AstraZeneca shares in Q2 2026, an estimated $95.5K.
  • AstraZeneca made up 3.37% of Woodley Farra Manion Portfolio Management's portfolio in Q2 2026, its #8 holding.
  • Woodley Farra Manion Portfolio Management first reported a position in AstraZeneca in Q3 2023 and has held it in 10 quarters since.
  • Woodley Farra Manion Portfolio Management's AstraZeneca position peaked at $72.8M in Q1 2026.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Woodley Farra Manion Portfolio Management's 13F filing for Q2 2026, filed 10 Aug 2026.